Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butyrate enemas for postoperative intestinal motility in Hirschsprung’s disease
2025-523094-42-00Phase 3Authorised
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of sodium butyrate in aganglionosis (HSCR) (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Planned start Dec 2025; status: authorised.
02
Drugs
sodium butyrate
03
Conditions
aganglionosis (HSCR)
Beyond the preview
Go deeper on 2025-523094-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523094-42-00.